Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Merck snaps up cancer drug from China’s Kelun in $1.4bn deal

SwanBio raises $56m for rare neurological disease gene therapy

KOL Validation: An Opportunity To Benchmark Mindset

Digital health body publishes best practice guide for DTx developers

AstraZeneca buys into startup RQ Bio’s COVID antibodies

Avillion

astrazeneca-sign

Market Access/ News/ News/ News/ R&D

AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial

Eloise McLennan albuterol, asthma, Astra Zeneca, Avillion, budesonide 0 Comment

An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients with asthma for

X

AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial

https://pharmaphorum.com/news/astrazeneca-avillion-first-in-class-combination-inhaler/

Merck-sign

News/ News/ R&D

Avillion/Merck psoriasis nanobody hits the mark in phase 2

Phil Taylor Avillion, dermatology, Immunology and inflammation, Merck KGaA, nanobody, psoriasis 0 Comment

UK biotech Avillion has reported positive mid-stage results with chronic psoriasis drug sonelokimab, which it is developing with

X

Avillion/Merck psoriasis nanobody hits the mark in phase 2

https://pharmaphorum.com/news/avillion-merck-psoriasis-nanobody-hits-the-mark-in-phase-2/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval
AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
AstraZeneca extends oncology partnership with Proteros
Novel drug to tackle inflammatory diseases begins trial

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com